A case of temporomandibular joint dislocation caused by rosuvastatin calcium tablets
10.12173/j.issn.1005-0698.202312027
- VernacularTitle:瑞舒伐他汀钙片致颞下颌关节脱位1例
- Author:
Jizhi CHEN
1
;
Bohan LI
;
Guoji XIA
Author Information
1. 中国人民解放军联勤保障部队第九○八医院药剂科(南昌 330002)
- Keywords:
Rosuvastatin calcium tablets;
Temporomandibular joint dislocation;
Adverse drug reactions
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(2):236-240
- CountryChina
- Language:Chinese
-
Abstract:
A 50-year-old female presented with bilateral cervical arteriosclerosis and right-sided plaque formation,after 25 d of treatment with rosuvastatin calcium tablets(20 mg,po,qn),the patient developed temporomandibular joint dislocation,the adverse reactions occurred again after giving manipulative repositioning.The patients were healthy,had no history of trauma and related diseases in stomatology,no history of drug allergy,patients did not open their mouth loudly at the onset of the disease,no external factors affecting the use of drugs during the combined use of other drugs.It was considered"very likely"that the dislocation of the jaw joint was caused by rosuvastatin calcium tablets.The patients were followed up for 3 months after the treatment of manipulative repositioning and other treatments,did not have any further dislocation of the temporomandibular joint dislocation.It is suggested that when using rosuvastatin calcium in clinical practice,attention should be paid to strengthening drug observation to ensure drug safety.
